Gunars Valkirs
49Patents
24h-index
24Co-inventors
85Inventor score
Filing activity: May 11, 1984 → Feb 24, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4632901A | Method and apparatus for immunoassays | Emerging Cross-Sectional Technologies | 285 | Expired |
| US6057098A | Polyvalent display libraries | Chemistry; Metallurgy | 220 | Expired |
| US5922615A | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network | Emerging Cross-Sectional Technologies | 175 | Expired |
| US5939272A | Non-competitive threshold ligand-receptor assays | Emerging Cross-Sectional Technologies | 139 | Expired |
| US4727019A | Method and apparatus for immunoassays | Emerging Cross-Sectional Technologies | 135 | Expired |
| US5028535A | Threshold ligand-receptor assay | Emerging Cross-Sectional Technologies | 121 | Expired |
| US5480792A | Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays | Emerging Cross-Sectional Technologies | 107 | Expired |
| US5089391A | Threshold ligand-receptor assay | Emerging Cross-Sectional Technologies | 105 | Expired |
| US5985579A | Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays | Emerging Cross-Sectional Technologies | 104 | Expired |
| US5851776A | Conjugates and assays for simultaneous detection of multiple ligands | Physics | 95 | Expired |
| US5679526A | Threshold ligand-receptor assay | Emerging Cross-Sectional Technologies | 94 | Expired |
| US5525524A | Crosstalk inhibitors and their uses | Emerging Cross-Sectional Technologies | 93 | Expired |
| US6348318B1 | Methods for concentrating ligands using magnetic particles | Emerging Cross-Sectional Technologies | 79 | Expired |
| US6297060A | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network | Emerging Cross-Sectional Technologies | 54 | Expired |
| US6794132B2 | Human antibodies | Chemistry; Metallurgy | 54 | Expired |
| US7361473B2 | Diagnostic markers of acute coronary syndrome and methods of use thereof | Physics | 51 | Expired |
| US6828110B2 | Assays for detection of Bacillus anthracis | Emerging Cross-Sectional Technologies | 49 | Expired |
| US6680209B1 | Human antibodies as diagnostic reagents | Emerging Cross-Sectional Technologies | 44 | Expired |
| US6420113B1 | Chimeric polyclonal antibodies | Physics | 43 | Expired |
| US6503722B1 | Diagnostic tests and kits for Clostridium difficile | Emerging Cross-Sectional Technologies | 41 | Expired |
| US7135287B1 | Human antibodies | Physics | 39 | Expired |
| US5965375A | Diagnostic tests and kits for Clostridium difficile | Emerging Cross-Sectional Technologies | 38 | Expired |
| US6302919A | Reverse-flow centrifugal filtration method | Performing Operations; Transporting | 36 | Expired |
| US7427490B2 | Diagnostic markers of stroke and cerebral injury and methods of use thereof | Emerging Cross-Sectional Technologies | 28 | Expired |
| US7608406B2 | Diagnostic markers of stroke and cerebral injury and methods of use thereof | Physics | 21 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.